Does 3H-imipramine binding asymmetry indicate psychiatric illness?

Area of Science:

• Neuroscience
• Psychiatry

Background:

• Serotonin is an inhibitory neurotransmitter in the human brain.
• A weakened inhibitory effect of serotonin may be implicated in psychiatric disorders.

Purpose of the Study:

• To investigate the asymmetry of serotonin transporter binding sites in the frontal cortex of psychiatric patients.
• To explore the role of the serotonergic system in the development of psychiatric conditions.

Main Methods:

• Examined tritiated imipramine binding sites (Bmax) in the frontal cortices of homicide victims (n=6) and controls (n=6).
• Compared Bmax values between the left and right hemispheres of both groups.
• Controlled for age, gender, and postmortem delay between groups.

Main Results:

• Control subjects showed significantly higher Bmax in the right frontal cortex compared to the left.
• Homicide victims with psychiatric conditions exhibited significantly higher Bmax in the left frontal cortex.
• One homicide victim without a psychiatric record did not show this hemispheric asymmetry.

Conclusions:

• The study suggests a potential alteration in serotonin transporter asymmetry in the frontal cortex of individuals with psychiatric disorders.
• Findings support a direct role for the serotonergic mechanism in the pathophysiology of psychiatric conditions.
• Hemispheric asymmetry of serotonin binding sites may be a biomarker for psychiatric illness.